Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Operating Expenses: 2009-2021

Historic Other Operating Expenses for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to -$53,000.

  • Avadel Pharmaceuticals' Other Operating Expenses fell 101.88% to -$53,000 in Q1 2021 from the same period last year, while for Mar 2021 it was -$39.7 million, marking a year-over-year decrease of 339.20%. This contributed to the annual value of -$53,000 for FY2021, which is 100.12% down from last year.
  • Avadel Pharmaceuticals' Other Operating Expenses amounted to -$53,000 in FY2021, which was down 100.12% from $45.8 million recorded in FY2020.
  • Avadel Pharmaceuticals' Other Operating Expenses' 5-year high stood at $91.2 million during FY2018, with a 5-year trough of -$53,000 in FY2021.
  • Moreover, its 3-year median value for Other Operating Expenses was $19.4 million (2019), whereas its average is $21.7 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 305.47% in 2018, then crashed by 100.12% in 2021.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Other Operating Expenses stood at $22.5 million in 2017, then spiked by 305.47% to $91.2 million in 2018, then plummeted by 78.76% to $19.4 million in 2019, then soared by 136.10% to $45.8 million in 2020, then slumped by 100.12% to -$53,000 in 2021.